BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11201721)

  • 1. Diabetes. The missing link with obesity?
    Flier JS
    Nature; 2001 Jan; 409(6818):292-3. PubMed ID: 11201721
    [No Abstract]   [Full Text] [Related]  

  • 2. The hormone resistin links obesity to diabetes.
    Steppan CM; Bailey ST; Bhat S; Brown EJ; Banerjee RR; Wright CM; Patel HR; Ahima RS; Lazar MA
    Nature; 2001 Jan; 409(6818):307-12. PubMed ID: 11201732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistin, obesity, and insulin resistance--the emerging role of the adipocyte as an endocrine organ.
    Shuldiner AR; Yang R; Gong DW
    N Engl J Med; 2001 Nov; 345(18):1345-6. PubMed ID: 11794158
    [No Abstract]   [Full Text] [Related]  

  • 4. Resistin: a new link between obesity and insulin resistance?
    Vidal-Puig A; O'Rahilly S
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):437-8. PubMed ID: 11678824
    [No Abstract]   [Full Text] [Related]  

  • 5. [Glucose metabolism in adipose tissue].
    Inoue A; Tobe K; Suzuki R; Kadowaki T
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():673-80. PubMed ID: 12430302
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistin and obesity-associated insulin resistance.
    Steppan CM; Lazar MA
    Trends Endocrinol Metab; 2002; 13(1):18-23. PubMed ID: 11750858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. You are what you secrete.
    Saltiel AR
    Nat Med; 2001 Aug; 7(8):887-8. PubMed ID: 11479613
    [No Abstract]   [Full Text] [Related]  

  • 8. Resistin--resistant to defining its role.
    Smith U
    Obes Res; 2002 Jan; 10(1):61-2. PubMed ID: 11786603
    [No Abstract]   [Full Text] [Related]  

  • 9. [The importance of adipose tissue for development of obesity and diabetes mellitus type 2].
    Hollung K; Reseland JE; Ranheim T; Haugen F; Drevon CA
    Tidsskr Nor Laegeforen; 2003 Feb; 123(3):311-4. PubMed ID: 12640896
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of adipocytokines and insulin resistance.
    Fasshauer M; Paschke R
    Diabetologia; 2003 Dec; 46(12):1594-603. PubMed ID: 14605806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity?
    Rea R; Donnelly R
    Diabetes Obes Metab; 2004 May; 6(3):163-70. PubMed ID: 15056123
    [No Abstract]   [Full Text] [Related]  

  • 12. Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids.
    Juan CC; Au LC; Fang VS; Kang SF; Ko YH; Kuo SF; Hsu YP; Kwok CF; Ho LT
    Biochem Biophys Res Commun; 2001 Dec; 289(5):1328-33. PubMed ID: 11741341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance in type 2 diabetes -- role of the adipokines.
    Arner P
    Curr Mol Med; 2005 May; 5(3):333-9. PubMed ID: 15892652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor alpha is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes.
    Fasshauer M; Klein J; Neumann S; Eszlinger M; Paschke R
    Biochem Biophys Res Commun; 2001 Nov; 288(4):1027-31. PubMed ID: 11689013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistin - a mediator of obesity-associated insulin resistance or an innocent bystander?
    Ukkola O
    Eur J Endocrinol; 2002 Nov; 147(5):571-4. PubMed ID: 12444887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current biology of resistin.
    Steppan CM; Lazar MA
    J Intern Med; 2004 Apr; 255(4):439-47. PubMed ID: 15049878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity.
    Vendrell J; Broch M; Vilarrasa N; Molina A; Gómez JM; Gutiérrez C; Simón I; Soler J; Richart C
    Obes Res; 2004 Jun; 12(6):962-71. PubMed ID: 15229336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in glycemia by leptin administration or high- fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis.
    Asensio C; Cettour-Rose P; Theander-Carrillo C; Rohner-Jeanrenaud F; Muzzin P
    Endocrinology; 2004 May; 145(5):2206-13. PubMed ID: 14962997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects.
    Lee JH; Chan JL; Yiannakouris N; Kontogianni M; Estrada E; Seip R; Orlova C; Mantzoros CS
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4848-56. PubMed ID: 14557464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes.
    McTernan PG; Fisher FM; Valsamakis G; Chetty R; Harte A; McTernan CL; Clark PM; Smith SA; Barnett AH; Kumar S
    J Clin Endocrinol Metab; 2003 Dec; 88(12):6098-106. PubMed ID: 14671216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.